Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment.
Saved in:
| Title: | Developing CAR-T/NK cells that target EphA2 for non-small cell lung cancer treatment. |
|---|---|
| Authors: | Kim SM; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea., Lee SY; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea., Kim SI; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea.; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea., Bae JY; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea.; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea., Hong JT; College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju-si, Chungbuk, Republic of Korea., Jo S; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea., Kim JH; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea., Chung HY; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungbuk, Republic of Korea., Kim TD; Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.; Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Republic of Korea. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Mar 13; Vol. 16, pp. 1448438. Date of Electronic Publication: 2025 Mar 13 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1448438 |
